Search
for
Sort by
Research 241–270 of 580
- Role of bulge epidermal stem cells and TSLP signaling in psoriasis
- JAK inhibition decreases the autoimmune burden in Down syndrome
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Application of Baricitinib in Dermatology
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Janus kinase inhibitors for alopecia areata: A narrative review
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Integrating stem cell biology and organoid technology for skin regenerative therapies
- Regulation of stem cell function by protein ubiquitylation
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Immune therapies for alopecia areata: evidence and new perspectives
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Shifting IRES versus Cap-initiated translation during homeostatic stem cell differentiation and stress
- Exploring novel management options for alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis